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Summary and Implications 
 We hypothesized that meloxicam administration to beef 
steers before shipping may be effective at reducing the 
impact of transportation on stress biomarkers. Circulating 
physiological biomarkers of stress were analyzed in a 
transportation trial between a meloxicam treatment group 
and a placebo treatment group. There were significant 
differences in stress biomarkers between treatment groups 
following transport. This suggests that there may be 
practical benefits for the use of long-acting non-steroidal 
anti-inflammatory drugs (NSAIDs), specifically meloxicam, 




Long distance transportation of calves intended for beef 
production is a common practice in the United States. 
Immunosuppression after transportation predisposes calves 
to developing bovine respiratory disease (BRD), which 
commonly occurs in the first 45 days of arrival and is 
associated with 65 to 80 % morbidity and 35 - 55 % 
mortality. BRD is estimated to cost the beef industry $500 
million annually. Therefore, even a modest reduction in 
stress after transportation could have a significant economic 
benefit for livestock producers.  
 Transportation is associated with an increase in 
circulating pro-inflammatory cytokines in cattle leading to 
the initiation of an inflammatory reaction. Previous studies 
support the hypothesis that extended exposure to a non-
steroidal anti-inflammatory drug (NSAID) may reduce 
stress and improve performance after castration and 
dehorning. Meloxicam is an NSAID approved in Canada for 
pain relief in calves after disbudding. Meloxicam was found 
to reduce the incidence of BRD in calves after castration 
when administered on arrival at the feedlot.  However, a 
similar effect was not observed in calves received as steers. 
The objective of this study was to assess stress biomarkers 
and inflammatory mediators in beef steers that received oral 
meloxicam or a placebo before long distance transportation.   
 
Materials and Methods 
Ninety-seven medium-large frame, horned & polled, 
Brahman, and Angus X Brahman crossbred steers aged 15 
to 17 months, weighing 201 to 465 kg were procured from 
the Brown Loam Experiment Station at the Mississippi State 
University research farm near Raymond, MS after a 32 
week backgrounding period. Calves were blood sampled at 
time point 0 hour. After sampling, treatment with either 
meloxicam or placebo was initiated. Calves were shipped 
approximately 1,316 km from Raymond, MS to a feedlot 
facility near Tabor, IA in 2 truckloads carrying 48 and 49 
calves respectively. Loading was coordinated for the trucks 
to arrive at the 24 hour time point. Then, after a 16 hour 
transportation event that concluded approximately 24 hours 
after baseline blood collection occurred, a follow up 
sampling took place at 144 hours.   
 
Results and Discussion 
 An increase in neutrophil, platelet, monocyte, white 
blood cell and red blood cell counts occurred after 
transportation (P <  0.0001) and a decrease in lymphocyte 
count was observed (P < 0.0001). Meloxicam treatment 
reduced the stress-induced neutrophilia (P = 0.0072) shown 
in Figure 1, and circulating monocyte count (P = 0.013) on 
arrival shown in Figure 2. Mean corpuscle hemoglobin (P = 
0.05), mean corpuscle volume (P = 0.05) and lymphocyte 
count (P = 0.05) was also greater in the placebo calves 
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compared with meloxicam calves after transportation. 
Furthermore, HP-MMP-9 complexes, TCO2, TNFα, plasma 
proteins and SP increased. Cortisol decreased after shipping 
(P < 0.01). MEL treatment tended to reduce serum cortisol 
concentrations (P = 0.08) and there was evidence of a time-
by-treatment interaction (P = 0.04).  An inverse relationship 
between plasma MEL concentrations and circulation 
cortisol concentrations (P = 0.002), neutrophil (P = 0.04) 
and basophil counts (P = 0.03) was also observed. The 
results suggest that meloxicam administration may reduce 
the impact of long-distance transportation on circulating 
physiological biomarkers of stress and inflammation in beef 
calves. 
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Figure 2. Monocyte levels between treatment groups 
over time. 
